20% subcutaneous immunoglobulin therapy.
Results at ASHP 2019 suggest potential for administration errors without proper guidance.
Results from a poster at ASHP 2019.
Pharmacists provide clinical training and operational skillsets.
Ultra-rare, potentially life-threatening genetic disease.
Hemoglobin S Polymerization inhibitor oral treatment.
The infractions that are most likely to get your pharmacy fined—and what you can learn from them.
Strategies include nonpharmacologic therapies, nonopioid medications, and opioid rotation.
From medications to novel treatment methods, a guide to helping your migraine patients.
Direct and concise information will dissuade dangerous use.